(Q36258130)

13 August 2017

1 reference

title

A guide to antibiotic resistance in bacterial skin infections (English)

1 reference

13 August 2017

main subject

antibiotic resistance

1 reference

Perera G

1

1 reference

13 August 2017

Hay R

series ordinal

2

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Journal of the European Academy of Dermatology and Venereology

13 August 2017

published in

1 reference

13 August 2017

volume

19

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

531-545

1 reference

Resistance to antimicrobial drugs--a worldwide calamity

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

A functional classification scheme for beta-lactamases and its correlation with molecular structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

An elegant means of self-protection in gram-negative bacteria by recognizing and extruding xenobiotics from the periplasmic space

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Evolution and spread of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Conjugal transfer of plasmids and antibiotic resistance among Escherichia coli isolated from animals in a rural area in Sarawak (Malaysia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

The role of conjugative transposons in spreading antibiotic resistance between bacteria that inhabit the gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Characterization of class I integrons in clinical strains of Salmonella enterica subsp. enterica serovars Typhimurium and Enteritidis from Norwegian hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Fatal coagulase-negative staphylococci infection after bone marrow transplantation in a patient with persistent adverse reactions to vancomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Coagulase-negative Staphylococci in Danish blood cultures: species distribution and antibiotic susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

The effect of antibiotics on the production of superantigen from Staphylococcus aureus isolated from atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Fusidic acid in dermatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Fusidic acid resistance in Staphylococcus aureus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Prevalence of vancomycin-resistant enterococci in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

The VISA/GISA problem: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Role of Mobile DNA in the Evolution of Vancomycin-Resistant Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Safety and tolerability of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Oxazolidinone antibacterial agents: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Linezolid: an oxazolidinone antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Spread of Staphylococcus aureus in hospitals: causes and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Trying to control MRSA causes more problems than it solves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Investigating the bacterial barrier properties of four contemporary wound dressings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

The microbiology of necrotizing soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Antibiotic resistance in group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Epidemiology of penicillin-resistant pneumococci in a Merseyside Health District over a 14-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Importance of dose and duration of beta-lactam therapy in nasopharyngeal colonization with resistant pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Two novel assays for the detection of haemin-binding properties of antimalarials evaluated with compounds isolated from medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Propionibacterium acnes resistance: a worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Pseudomonas aeruginosa infections of intact skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Ciprofloxacin-resistant Pseudomonas keratitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Erythromycin resistance in Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

Effect of drug concentration on emergence of macrolide resistance in Mycobacterium avium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01296.X

10.1111/J.1468-3083.2005.01296.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference